ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...
Specialists address the intricate factors between comorbidities, efficacy, and tolerance, which influence their treatment approaches at the time of diagnosis. Mark Socinski, MD: Martin, we have seen ...
Abbreviations: CCOP, Community Clinical Oncology Program; NCI, National Cancer Institute; NSCLC, non–small-cell lung cancer; QOL, quality of life; SD, standard deviation; VA, Veterans Affairs. On the ...
Retrospective analysis among 1418 patients with haematologic malignancies seen at Dana-Farber Cancer Institute between 2007 and 2014. We analysed physician–patient agreement of Eastern Cooperative ...
The standard treatment for patients with advanced-stage non-small-cell lung cancer with a performance status of 2 is unclear because of the heterogeneity of this population. Although a recent trial ...
In most types of cancer, functional status is the determining factor for both conventional treatment and clinical trial eligibility. It is often also a primary driver of prognosis independent of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results